MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/wjo2.70114

Медицинская библиотека · World journal of otorhinolaryngology - head and neck surgery · 2026

Safety, Efficacy, and Mechanism of Action of Budesonide in Rhinitis and Rhinosinusitis: A Systematic Review.

Kennedy David W, Cheng Lei, Wang De-Yun

СтатьяОбзорПеревод в очереди

Аннотация

OBJECTIVE

Budesonide is a corticosteroid with unique pharmacokinetic and pharmacodynamic properties that has been a frontline treatment for patients with allergic rhinitis (AR) and chronic rhinosinusitis (CRS) since the 1990s. As research on budesonide continues to produce new insights, our aim was to synthesize recent investigations and provide up-to-date information on safety, clinical, and mechanism of action (MOA) outcomes.

DATA SOURCES: Searches were restricted to PubMed from 2014/01/01 to 2025/02/26. Clinical investigations in the primary therapeutic area of rhinitis, sinusitis, or rhinosinusitis with adult patients receiving budesonide were included.

REVIEW

METHODS

Results were screened, and findings from eligible articles were assessed for safety, efficacy, and/or MOA outcomes.

RESULTS

Overall, 31 articles were included. CRS was the primary indication in 19 studies and rhinitis in 12 (predominantly AR). Six studies investigated hypothalamic-pituitary-adrenal (HPA) axis suppression, and 2 studies assessed intraocular pressure; budesonide did not adversely affect either outcome, even with long-term, high-dose, high-volume nasal irrigations. Twelve studies of budesonide monotherapy generally showed improved efficacy outcomes. Eight studies of budesonide combination therapies, predominantly in patients with moderate-to-severe AR, generally showed improved efficacy versus budesonide monotherapy. MOA data were reported across seven studies, with anti-inflammatory alterations observed across the nasal mucosa, nasal secretions, nasal polyps, and peripheral blood after budesonide treatment.

CONCLUSIONS

Safety outcomes were favorable across various budesonide delivery systems, including high-dose, high-volume nasal irrigations, with no evidence of HPA axis suppression after long-term budesonide use. Budesonide demonstrated consistent efficacy that was underpinned by MOA data on its potent anti-inflammatory effects.

Для цитирования: Kennedy David W, Cheng Lei, Wang De-Yun. Safety, Efficacy, and Mechanism of Action of Budesonide in Rhinitis and Rhinosinusitis: A Systematic Review.. World journal of otorhinolaryngology - head and neck surgery. 2026. DOI: 10.1002/wjo2.70114.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.